G6PD deficiency
Information
- Disease name
- G6PD deficiency
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05096702 | Active, not recruiting | Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil | September 9, 2021 | September 9, 2023 | |
| NCT03529396 | Active, not recruiting | Phase 2 | Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients | July 20, 2018 | November 2023 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT05753150 | Completed | Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand | May 23, 2022 | October 1, 2023 | |
| NCT04146246 | Completed | Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates | November 11, 2019 | March 13, 2020 | |
| NCT02937363 | Completed | N/A | Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise | December 2016 | July 2017 |
| NCT04081272 | Completed | Effect of G6PD Deficiency on Red Blood Cell Storage | November 2012 | October 2017 | |
| NCT02434952 | Completed | Phase 4 | Safety and Tolerability of Low Dose Primaquine | October 2014 | |
| NCT04010695 | Completed | N/A | Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US | May 13, 2019 | September 19, 2019 |
| NCT04033640 | Completed | N/A | Evaluation of a Diagnostic to Identify Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Brazil | June 27, 2019 | December 31, 2019 |
| NCT04054661 | Completed | N/A | Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated Blood | August 12, 2019 | January 31, 2020 |
| NCT03655223 | Enrolling by invitation | Early Check: Expanded Screening in Newborns | October 15, 2018 | December 31, 2025 | |
| NCT05571748 | Not yet recruiting | N/A | Oxidative Stress, Carbohydrate Metabolism Disorders and G6PD Deficiency | February 2023 | June 2023 |
| NCT05879224 | Recruiting | N/A | Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia | August 7, 2023 | July 31, 2025 |
| NCT04088513 | Recruiting | Phase 4 | Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST) | January 22, 2020 | December 31, 2024 |
| NCT05874271 | Recruiting | N/A | Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea | July 10, 2023 | July 31, 2025 |
| NCT03337152 | Terminated | Phase 4 | Assessing a Risk Model for G6PD Deficiency | May 7, 2018 | October 21, 2018 |
| NCT04073953 | Unknown status | Phase 1 | Primaquine Enantiomers in G6PD Deficient Human Volunteers | September 1, 2020 | September 1, 2022 |
| NCT02937376 | Unknown status | Early Phase 1 | Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise | February 1, 2023 | November 1, 2023 |
| NCT05026489 | Unknown status | G6PD Deficiency in Infarction Patients in Shaanxi Province | November 1, 2021 | December 31, 2023 |